Clinical Trial Update: Avapritinib With Decitabine in Patients With SM-AHN [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the combination of avapritinib and decitabine in patients with systemic mastocytosis with an associated hematologic neoplasm; the trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Mastocytosis with An Associated Hematologic Neoplasm

Drugs mentioned

• Avapritinib (avapritinib)
• Decitabine (Decitabine)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Systemic Mastocytosis With an Associated Hematologic Neoplasm | Phase 1 | Status: RECRUITING